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Abstract. 
 
The absence of dystrophin complex leads to 
disorganization of the force-transmitting costameric cy-
toskeleton and disruption of sarcolemmal membrane 
integrity in skeletal muscle. However, it has not been 
determined whether the dystrophin complex can form a 
mechanically strong bond with any costameric protein. 
We performed confocal immunoﬂuorescence analysis 
of isolated sarcolemma that were mechanically peeled 
from skeletal ﬁbers of mouse hindlimb muscle. A popu-
lation of 
 
g
 
-actin ﬁlaments was stably associated with 
sarcolemma isolated from normal muscle and displayed 
a costameric pattern that precisely overlapped with 
dystrophin. However, costameric actin was absent from 
 
all sarcolemma isolated from dystrophin-deﬁcient 
 
mdx
 
 
mouse muscle even though it was localized to cos-
tameres in situ. Vinculin, 
 
a
 
-actinin, 
 
b
 
-dystroglycan and 
utrophin were all retained on 
 
mdx
 
 sarcolemma, indicat-
ing that the loss of costameric actin was not due to gen-
eralized membrane instability. Our data demonstrate 
that the dystrophin complex forms a mechanically 
strong link between the sarcolemma and the costameric 
cytoskeleton through interaction with 
 
g
 
-actin ﬁlaments. 
Destabilization of costameric actin ﬁlaments may also 
be an important precursor to the costamere disarray 
observed in dystrophin-deﬁcient muscle. Finally, these 
methods will be broadly useful in assessing the mechan-
ical integrity of the membrane cytoskeleton in dystro-
phic animal models lacking other costameric proteins.
Key words: dystrophin • actin • muscular dystrophy • 
membrane skeleton • costameres
 
Introduction
 
In skeletal muscle, dystrophin is associated with a large,
oligomeric complex of proteins that includes dystroglycans,
sarcoglycans, dystrobrevins, syntrophins and sarcospan
(Straub and Campbell, 1997). The dystrophin complex is
generally thought to link the actin-based cortical cytoskel-
eton and laminin-2 in the extracellular matrix (Ervasti and
Campbell, 1993). Genetic ablation of dystrophin or other
components in the complex results in a variety of muscular
dystrophies, which are often associated with defects in sar-
colemmal membrane integrity (Petrof et al., 1993; Straub
et al., 1997; Duclos et al., 1998; Cote et al., 1999). Thus, it is
hypothesized that one important function of the dystro-
phin complex is to mechanically stabilize the sarcolemmal
membrane from shear stresses imposed during eccentric
muscle contraction (Petrof et al., 1993). A mechanically
strong attachment of dystrophin with the sarcolemmal
membrane has already been demonstrated (Straub et al.,
1992). Regarding possible interaction with the cortical cy-
toskeleton, dystrophin is located adjacent to the cytoplas-
mic face of the sarcolemmal membrane in a discrete, rib-
like lattice termed costameres (Porter et al., 1992; Straub
et al., 1992), a cytoskeletal protein assembly that links the
force-generating sarcomeric apparatus to the sarcolemmal
membrane (Pardo et al., 1983a; Craig and Pardo, 1983).
Costameres transmit contractile forces laterally through
the sarcolemmal membrane to the basal lamina (Da-
nowski et al., 1992), which may be important for maintain-
ing uniform sarcomere length between active and resting
muscle fibers of different motor units. While dystrophin is
not required for the assembly of several proteins compris-
ing costamere-like structures, the absence of dystrophin in
humans and mice leads to an altered costameric lattice
(Minetti et al., 1992, 1994; Porter et al., 1992; Ehmer et al.,
 
Address correspondence to Dr. James M. Ervasti, Department of Physiol-
ogy, 127 Service Memorial Institutes, 1300 University Avenue, Madison,
WI 53706. Tel.: (608) 265-3419. Fax: (608) 265-5512. E-mail: ervasti@
physiology.wisc.edu 
The Journal of Cell Biology, Volume 150, 2000 1210
 
1997; Williams and Bloch, 1999). These data suggest that
dystrophin plays an important role in organizing or stabi-
lizing costameres, possibly via direct binding to actin fila-
ments. Biochemical studies have demonstrated that puri-
fied dystrophin complex can bind actin filaments with an
apparent dissociation constant in the sub-micromolar
range (Rybakova et al., 1996). However, it has been diffi-
cult to assess whether the affinity of the dystrophin/F-actin
interaction measured in vitro is sufficient to support a me-
chanically strong interaction in vivo.
To address this question, we isolated inside-out sar-
colemmal membranes by mechanically peeling the mem-
branes from single myofibers teased from normal mouse
hindlimb muscles. We used confocal immunofluorescence
microscopy to visualize the cytoskeletal proteins retained
on the sarcolemma without interference from sarcomeric
proteins (Straub et al., 1992). In brief, we have obtained
the first evidence demonstrating that the dystrophin com-
plex is necessary for a mechanically strong physical link-
age between the sarcolemmal membrane and 
 
g
 
-actin of
the costameric cytoskeleton. Furthermore, our data point
toward destabilization of 
 
g
 
-actin filaments as a possible in-
termediate between dystrophin deficiency and global dis-
organization of the costameric apparatus (Minetti et al.,
1992, 1994; Porter et al., 1992; Ehmer et al., 1997; Williams
and Bloch, 1999). Finally, our approach should be broadly
applicable to assessing the contributions made by other
costameric proteins toward the macromolecular organiza-
tion and mechanical integrity of the membrane cytoskele-
ton in skeletal muscle.
 
Materials and Methods
 
Antibodies and Fluorescent Probes
 
Rabbit 2 polyclonal antiserum against dystrophin was obtained from an
animal immunized with a recombinant protein encoding the first 246
amino acids of human dystrophin (DYS246), which was expressed and pu-
rified as previously described (Rybakova et al., 1996). Rabbit 56 poly-
clonal antiserum against a peptide corresponding to the last 12 amino ac-
ids of utrophin (Ohlendieck et al., 1991) was the kind gift of Dr. Kevin
Campbell (University of Iowa, Iowa City, IA). The pan-actin monoclonal
antibody C4 was purchased from ICN. Monoclonal antibodies specific for
 
a
 
-actinin, 
 
a
 
-sarcomeric actin, 
 
b
 
-actin, and vinculin were purchased from
Sigma-Aldrich. The preparation and characterization of 
 
g
 
-actin polyclonal
antibodies was previously described (Otey and Bulinski, 1988). The 
 
b
 
-dys-
 
troglycan monoclonal antibody was purchased from Vector Laborato-
ries. FITC- and TRITC-conjugates of anti-rabbit IgG and anti-mouse
IgG were purchased from Jackson ImmunoResearch Laboratories, Inc.
Alexa488- and Alexa568-conjugates of phalloidin, anti-rabbit IgG and
anti-mouse IgG were purchased from Molecular Probes.
 
Mechanical Isolation of Single Myofibers
and Sarcolemma
 
Age matched, or littermate control, C57BL/10ScSn-DMD
 
mdx
 
/J, or C57BL/
6J-Lama2
 
dy
 
 mice were obtained from Jackson ImmunoResearch Labora-
tories. The vastus lateralis was dissected from tendon to tendon in ice-cold
Ringers solution and transferred to a 0.5-ml drop of relaxing solution
(100 mM BES, 15 mM creatine phosphate, 5 mM DTT, 4.74 mM ATP,
5.43 mM MgCl
 
2
 
, 7 mM EGTA, and 0.02 mM CaCl
 
2
 
 with the ionic strength
adjusted to 180 mM with potassium proprionate, pH 7.0) surrounded by
silicone oil. To isolate sarcolemma membranes, one end of a single myofi-
ber was secured with a very fine forceps, the sarcolemma was hooked near
the forceps with a stainless steel micro-needle (
 
,
 
100 
 
m
 
m diameter filed to
a fine point) and rolled down and off the free end of the myofiber. Iso-
lated sarcolemma and mechanically peeled or intact single myofibers were
transferred with fine-tipped glass micropipets to a 0.02-ml drop of relaxing
solution stationed on a gelatin-coated glass slide. Isolated sarcolemma and
mechanically peeled myofibers were fixed for 5 min with 4% paraformal-
dehyde in PBS. To assess the location of 
 
g
 
-actin in situ, intact myofibers
from the vastus lateralis were fixed and permeabilized for 5 min with 4%
paraformaldehyde and 0.1% Triton X-100 in PBS.
 
Immunofluorescence Analysis
 
Isolated myofibers and sarcolemmal membranes were blocked for 30 min
at room temperature with 5% goat serum in PBS and incubated with pri-
mary antibodies overnight at 4
 
8
 
C. The samples were washed with PBS, in-
cubated with the appropriate fluorescently tagged secondary antibodies
for 30 min at 37
 
8
 
C, rinsed, and sealed under coverslips in an anti-fade solu-
tion. Confocal microscopy was performed with a Bio-Rad MRC1000 scan
head mounted transversely to an inverted Nikon Diaphot 200 microscope
in the Keck Neural Imaging Lab at the University of Wisconsin. The kryp-
ton/argon mixed gas air–cooled laser was set to allow only the 488- and
568-nm excitation lines, while the green and red emission signals were di-
rected to separate photomultiplier tubes. Images were collected during a
sequential scan to reduce the possibility of fluorescence bleed-through. To
further verify that bleed-through of the green signal was not contaminat-
ing the red signal, serial optical sections (z series) were collected in some
experiments using both single channel and double channel modes. Digital
images were cropped using Adobe Photoshop 5.0 and figure montages
prepared with Adobe Illustrator 8.0.
 
Miscellanea
 
The dystrophin/utrophin-glycoprotein complexes were amplified for im-
munoblot analysis from control and 
 
mdx
 
 total skeletal muscle membranes
(Ohlendieck and Campbell, 1991) using digitonin extraction and WGA-
Sepharose chromatography (Ervasti et al., 1990). Immunofluorescence
analysis of frozen cryostat sections from control and 
 
mdx
 
 muscle was per-
formed as previously described (Ervasti and Campbell, 1991).
 
Results and Discussion
 
A Population of Actin Filaments Is Tightly Associated 
with Costameres on Isolated Sarcolemma
 
Costameric proteins are typically visualized by immuno-
fluorescence analysis of glancing longitudinal cryosections
(Craig and Pardo, 1983; Porter et al., 1992), or in perme-
 
abilized single myofibers from mature skeletal muscle
(Straub et al., 1992; Ehmer et al., 1997). If used in combi-
nation with widely available actin probes, analysis of dys-
trophin/actin colocalization by either of these methods is
greatly complicated by the intense and ubiquitous signal
provided by sarcomeric actin (Rybakova, I.N., and J.M.
Ervasti, unpublished results). Therefore, we adopted a
method (Straub et al., 1992) that would enable us to visu-
alize the costameres without interference from the sarco-
meric cytoskeleton. We isolated inside-out sarcolemmal
membranes by mechanical peeling of single myofibers
teased from normal mouse hindlimb muscles. Sarcolem-
mal membranes double stained with rabbit polyclonal
antibodies to dystrophin and a fluorescent conjugate of
phalloidin were examined by confocal immunofluores-
cence microscopy, which revealed closely overlapping cos-
tameric staining patterns consisting of alternately bright
and dark transverse bands (Fig. 1 a) with an average peri-
odicity of 2.8 
 
6
 
 0.3 
 
m
 
m (
 
n
 
 
 
5 
 
7). However, only phalloidin
stained the mechanically peeled myofibers (2.5 
 
m
 
m) while
no dystrophin staining was detected (Fig. 1 b). Analysis of
sarcolemma stained with other, better-characterized anti-
bodies to dystrophin yielded similar results. However, we
found that the rabbit 2 polyclonal antiserum to dystrophin
raised in our laboratory yielded the greatest signal-to- 
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noise. Since the rabbit 2 antiserum was used throughout
this study and had not been previously characterized, we
have included evidence documenting its specificity for dys-
trophin in Fig. 1 c. To confirm that phalloidin was appro-
priately reporting the presence of actin, we double stained
sarcolemma with rabbit 2 dystrophin antibodies and a well
documented pan-actin monoclonal antibody (C4) reactive
with all mammalian actin isoforms (Lessard, 1988). Again,
dystrophin and actin staining exhibited closely overlapping
staining patterns suggestive of costameres (Fig. 2, a–c). As
an additional control, similar staining patterns were ob-
served when sarcolemma were single-stained for dystro-
phin or actin. Finally, no staining was observed when fluo-
rescent secondary antibodies were incubated alone with
sarcolemma, nor did the secondary antibodies exhibit any
inappropriate species cross-reactivity that could poten-
tially explain the closely overlapping patterns obtained for
dystrophin and actin. Thus, we conclude that a population
of actin filaments and dystrophin are tightly associated with
 
the costameric cytoskeleton of normal skeletal muscle such
that both can withstand the rigors of mechanical peeling.
 
Costameric Actin Is Specifically Absent from 
Dystrophin-deficient Sarcolemma
 
Because dystrophin binds actin in vitro
 
 
 
(Rybakova et al.,
1996) and the costameric cytoskeleton is altered in dystro-
phin-deficient muscle (Minetti et al., 1992, 1994; Porter et
al., 1992; Ehmer et al., 1997; Williams and Bloch, 1999), we
hypothesized that costameric actin should display an ab-
normal staining pattern on sarcolemma isolated from dys-
trophin-deficient 
 
mdx
 
 mice. To our surprise, we observed
that costameric actin was completely absent from 
 
mdx
 
 sar-
colemma as reported by monoclonal antibody C4 (Fig. 2,
d–f), or phalloidin (Fig. 3, a–c). The absence of actin from
 
mdx
 
 sarcolemma can be most directly and simply ex-
plained through an actin stabilizing function normally per-
formed by dystrophin. Alternatively, the loss of actin from
 
mdx
 
 sarcolemma might not be specifically due to the ab-
sence of dystrophin but rather to some other aspect of the
dystrophic pathomechanism. However, we have detected
costameric actin in all 24 sarcolemma isolated from 8 dif-
ferent control mice while costameric actin was absent from
21 different sarcolemma obtained from 7 different 
 
mdx
 
mice. The animals used ranged from 2 to 6 months of age
with the isolated sarcolemmal diameters varying from 18–
60 
 
m
 
m for controls and 20–43 
 
m
 
m for 
 
mdx
 
 mice. Further-
more, we examined costameric actin distribution in sarco-
Figure 1. Dystrophin and F-actin colocalize on mechanically iso-
lated sarcolemma in a costameric pattern. Shown is a mechani-
cally isolated sarcolemma (a), or a skinned myofiber (b) both
stained with Alexa488-phalloidin (green) and rabbit 2 antiserum
to dystrophin (red). Red and green channels were collected si-
multaneously and areas of coincidence appear yellow. Shown on
the left in (c) are immunoblots containing WGA-Sepharose elu-
ates from detergent solubilized control and mdx skeletal muscle
membranes stained with rabbit 2 antiserum to dystrophin (Dys),
or rabbit 56 antiserum to utrophin (Utr). Shown on the right in c
are transverse cryosections of control and mdx skeletal muscle
stained with rabbit 2 antiserum to dystrophin. Bars: (b) 10 mm;
(c) 50 mm.
Figure 2. Costameric actin is absent from dystrophin-deficient
mdx sarcolemma. Shown are representative images of sarco-
lemma isolated from control (a–c), dystrophin-deficient mdx (d–
f), or laminin-2–deficient dy/dy (g–i) muscle stained with rabbit 2
antiserum to dystrophin (green) and monoclonal antibody C4 to
actin (red). Green (a, d, and g) and red (b, e, and h) channels
were collected separately, or simultaneously (c, f, and i) where
areas of coincidence appear yellow. Dark ovoid shaped areas are
nuclear lacunae, which mark the location of peripheral myonu-
clei before skinning (Straub et al., 1992). Bar, 10 mm. 
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lemma isolated from the hindlimb muscles of severely
dystrophic 
 
dy/dy
 
 mice. The 
 
dy/dy
 
 mouse is deficient
in laminin-2, the major extracellular matrix ligand for
 
a
 
-dystroglycan in the dystrophin-glycoprotein complex
(Campbell, 1995). In contrast to 
 
mdx
 
 muscle, the dystro-
phin-glycoprotein complex is normally expressed at the
sarcolemma of dy/dy muscle (Ohlendieck and Campbell,
1991) and shows little evidence of sarcolemmal membrane
damage (Straub et al., 1997). Sarcolemma isolated from
 
dy/dy
 
 muscle retained both dystrophin and actin in an
overlapping pattern (Fig. 2, g–i) similar to the costameric
distribution observed in non-dystrophic control sarco-
lemma (Fig. 2, a–c). These results suggest that in the ab-
sence of dystrophin, costameric actin is not stably associ-
ated with the sarcolemma membrane.
Because sarcolemmal integrity is compromised in dys-
trophin-deficient muscle (Straub et al., 1997), the absence
of costameric actin might simply reflect a nonspecific loss
of peripheral sarcolemmal proteins as a consequence of
the stresses imposed during mechanical peeling. However,
we found that both vinculin (Fig. 3 a) and 
 
a
 
-actinin (Fig. 4
e) were retained on sarcolemma isolated from 
 
mdx
 
 mus-
cle. Recently, both residual 
 
b
 
-dystroglycan and upregu-
lated utrophin in 
 
mdx
 
 muscle were shown to exhibit a cos-
tameric staining pattern in situ
 
 
 
(Williams and Bloch,
1999). Consistent with this study, we observed that 
 
b
 
-dys-
troglycan and utrophin were also retained on 
 
mdx
 
 sarco-
lemma and exhibited a costameric staining pattern (Fig. 3,
b–d). Importantly, these data indicate that the loss of cos-
tameric actin was not due to generalized weakness of the
sarcolemma membrane but is instead a specific conse-
quence of dystrophin deficiency. Furthermore, our data
suggest that utrophin either lacks the actin filament stabi-
lizing activity of dystrophin (Amann et al., 1999), or that
the amount of costameric utrophin in 
 
mdx
 
 muscle was not
sufficient to retain costameric actin on mechanically iso-
lated sarcolemma.
 
Costameric Actin Is Appropriately Expressed and 
Localized in mdx Muscle In Situ
 
The 
 
g
 
-actin isoform was previously shown to colocalize
with vinculin at costameres in chick skeletal muscle (Craig
and Pardo, 1983). However, the polyclonal antibody used
in this study (Craig and Pardo, 1983) did not significantly
stain the sarcolemma of mouse diaphragm (Pardo et al.,
1983b). Thus, it remained unclear which actin isoform(s)
may populate costameres of mammalian muscle. There-
fore, we stained normal sarcolemma with monoclonal anti-
bodies specific for 
 
a
 
-sarcomeric actin, or 
 
b
 
-actin, or a
polyclonal antibody raised against a peptide correspond-
ing to the unique amino-terminus of 
 
g
 
-actin (Otey and Bu-
linski, 1988). Only the 
 
g
 
-isoform antibody yielded a bright,
costameric pattern of staining while 
 
a
 
- and 
 
b
 
-specific anti-
bodies yielded only weak and diffuse background labeling
(Fig. 4, a–c). As was found using monoclonal antibody C4
(Fig. 2), or phalloidin (Fig. 3), the 
 
g
 
-actin staining pattern
evident on normal sarcolemma (Fig. 4, c and d) was absent
from dystrophin-deficient 
 
mdx
 
 sarcolemma (Fig. 4 e).
These data indicate that costameric actin appears to be ex-
clusively comprised of the 
 
g
 
-isoform.
It remained to be determined whether costameric actin
was absent from 
 
mdx
 
 muscle before mechanical peeling,
Figure 3. Retention of vinculin, b-dystroglycan and utrophin on
mdx Sarcolemma. Shown are images of mechanically isolated
sarcolemma from mdx (a–c) or control muscle (d) stained with
Alexa568-phalloidin (a–d) in red, and antibodies to vinculin (a),
b-dystroglycan (b), or utrophin (c and d) in green. Bar, 10 mm. Figure 4. Costameric g-actin is appropriately expressed and lo-
calized in mdx muscle in situ. Shown in a–c are images of sarco-
lemma from normal mouse muscle stained with antibodies spe-
cific to a-sarcomeric (a), b-nonmuscle (b), or g-actin (c). Shown
in d and e are images of control (d), or mdx sarcolemma (e) dou-
ble stained with monoclonal antibodies to a-actinin (green) and
polyclonal antibodies to g-actin (red). Areas of coincidence be-
tween the two probes appear yellow. Shown in f and g are images
of fixed and permeabilized myofibers from control (f) and mdx
(g) muscle stained with antibodies specific for g-actin. Bars, 10 mm. 
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or was lost as a result of the peeling procedure. Therefore,
we examined 
 
g
 
-actin staining in single fibers from control
and 
 
mdx
 
 muscle that were fixed and permeabilized, but
not mechanically peeled. Both control and 
 
mdx
 
 myofibers
exhibited peripheral 
 
g
 
-actin staining patterns marked by
regularly spaced transverse fluorescent bands of similar in-
tensities (Fig. 4, f and g). Finally, the 
 
g
 
-actin antibodies
also labeled the periphery of Z-lines in mechanically
peeled myofibers from both control and 
 
mdx
 
 muscle, how-
ever, the 
 
g
 
-actin signal appeared brighter on 
 
mdx
 
 myofi-
bers compared with controls (not shown). Taken together,
our results indicate that 
 
g
 
-actin is appropriately expressed
and assembled into costameres in 
 
mdx
 
 muscle, but that its
stable association with the sarcolemmal membrane is se-
verely compromised.
Based on its structure, protein interactions, and mem-
brane defects associated with its absence or abnormality in
dystrophic muscle, the dystrophin complex has long been
hypothesized to mechanically stabilize the sarcolemmal
membrane against the stresses imposed during muscle
contraction or stretch (Petrof et al., 1993; Campbell, 1995).
Whereas dystrophin is strongly anchored to the sarcolem-
mal membrane (Straub et al., 1992), no study has demon-
strated a mechanically strong linkage between dystrophin
and any component of the costameric cytoskeleton. Thus,
ours are the first data demonstrating that the dystrophin
complex is necessary for a mechanically strong physical
linkage between the sarcolemmal membrane and cos-
tameric 
 
g
 
-actin. Furthermore, our data point toward de-
stabilization of 
 
g
 
-actin filaments as a possible intermediate
between dystrophin deficiency and global disorganization
of the costameric apparatus (Porter et al., 1992; Minetti et al.,
1992, 1994; Ehmer et al., 1997; Williams and Bloch, 1999).
Complexes comprised of ankyrin/spectrin(Williams and
Bloch, 1999), vinculin/talin/
 
a
 
-actinin (Williams and Bloch,
1999) and intermediate filament/intermediate filament as-
sociated proteins (Milner et al., 1996; Andra et al., 1997;
Dalpe et al., 1999) are also localized to costameres and are
capable of binding actin (Fig. 5). Therefore, it is possible
that multiple, distinct costameric protein complexes act
synergistically to form a strong mechanical linkage be-
tween the sarcolemmal membrane and the force-generat-
ing sarcomeric apparatus. In support of this possibility,
targeted inactivation of desmin (Milner et al., 1996), plec-
tin (Andra et al., 1997), or BPAGn1/dystonin (Dalpe et
al., 1999) also cause muscular dystrophy and sarcolemmal
instability. Our methods should be valuable in further as-
sessing the macromolecular organization and mechanical
integrity of the membrane cytoskeleton in dystrophic ani-
mal models lacking other components of costameres.
Alternatively, dystrophin may be specifically designed
to mechanically stabilize costameric actin filaments. We
previously demonstrated that dystrophin contains two dis-
tinct and spatially separated actin binding sites located at
the amino terminus and middle rod domains (Rybakova
et al., 1996; Amann et al., 1998), which enables dystrophin
to form an extended lateral association with F-actin and
protect actin filaments from depolymerization in vitro
(Rybakova et al., 1996; Rybakova and Ervasti, 1997).
Studies by others suggest that the dystrophin carboxy-ter-
minal domain may also participate in binding actin, either
directly (Howard et al., 1998), or indirectly through 
 
a
 
-syn-
trophin (Iwata et al., 1998). Analysis of sarcolemma from
 
mdx
 
 mice transgenically expressing dystrophin constructs
deleted in different domains (Chamberlain et al., 1997), or
mice lacking 
 
a
 
-syntrophin (Kameya et al., 1999) will re-
solve which elements in the dystrophin complex are neces-
sary for strong actin filament association with the sar-
colemmal membrane. Finally, the methods used in this
study will be valuable in assessing whether utrophin over-
expression (Tinsley et al., 1998) can rescue the mechani-
cally strong linkage between costameric actin and the sar-
colemmal membrane observed in normal muscle.
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